University Researchers Are Seen as Enablers in Latest Major Drug Fraud

University Researchers Are Seen as Enablers in Latest Major Drug Fraud 1

Kris Connor, Getty Images

Attorney General Eric Holder: "These are not victimless crimes. Americans trust that the medications prescribed for their parents and grandparents, for their children, and for themselves are selected because they are in the patient's best interest."

Enlarge Image
close University Researchers Are Seen as Enablers in Latest Major Drug Fraud 1

Kris Connor, Getty Images

Attorney General Eric Holder: "These are not victimless crimes. Americans trust that the medications prescribed for their parents and grandparents, for their children, and for themselves are selected because they are in the patient's best interest."

Federal prosecutors on Thursday concluded another multibillion-dollar settlement with a major pharmaceutical company accused of illegally marketing its drugs.

In this case, the company was Johnson & Johnson, the total payment was $2.2-billion, and the key drug was Risperdal, which was approved by federal regulators to treat schizophrenia in adults but was being marketed for other patients, including children with behavioral problems.

As with similar instances involving